| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3244848
Max Phase: Preclinical
Molecular Formula: C24H27ClN6O5
Molecular Weight: 514.97
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCOC(=O)C[C@H](NC(=O)c1ccc(NCc2ccc3nc(N)nc(N)c3c2Cl)cc1)C(=O)OCC
Standard InChI: InChI=1S/C24H27ClN6O5/c1-3-35-18(32)11-17(23(34)36-4-2)29-22(33)13-5-8-15(9-6-13)28-12-14-7-10-16-19(20(14)25)21(26)31-24(27)30-16/h5-10,17,28H,3-4,11-12H2,1-2H3,(H,29,33)(H4,26,27,30,31)/t17-/m0/s1
Standard InChI Key: URPAFRKXOBUJCQ-KRWDZBQOSA-N
Associated Targets(non-human)
Dihydrofolate reductase 2343 Activities
Dihydrofolate reductase 93 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 514.97 | Molecular Weight (Monoisotopic): 514.1731 | AlogP: 2.67 | #Rotatable Bonds: 10 |
| Polar Surface Area: 171.55 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
| #RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: | CX Basic pKa: 6.72 | CX LogP: 2.33 | CX LogD: 2.29 |
| Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.29 | Np Likeness Score: -0.81 |
References
| 1. Hynes JB, Eason DE, Garrett CM, Colvin PL.. (1977) Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids., 20 (4): [PMID:850245] [10.1021/jm00214a030] |
Source
Source(1):